Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in novel molecular targets for antidepressants
Qingzhong Wang, Yogesh Dwivedi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110041-110041
Open Access | Times Cited: 24

Showing 24 citing articles:

Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood
Yue‐Ting Deng, Ya‐Nan Ou, Bang‐Sheng Wu, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2849-2857
Closed Access | Times Cited: 84
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Weiyi Yao, Xinting Hu, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Jasmine Tea Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-like Behavior in Rats via the Gut-Brain Axis
Yangbo Zhang, Jianan Huang, Yifan Xiong, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 99-99
Open Access | Times Cited: 49
Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies
Inés Moragrega, José Luis Rı́os
Planta Medica (2021) Vol. 87, Iss. 09, pp. 656-685
Open Access | Times Cited: 41
Effects of Histone Modification in Major Depressive Disorder
Man-Si Wu, Xiaojuan Li, Chenyue Liu, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 7, pp. 1261-1277
Open Access | Times Cited: 34
The emergence of antidepressant drugs targeting GABAA receptors: A concise review
Xénia Gonda, Frank I. Tarazi, Péter Döme
Biochemical Pharmacology (2024) Vol. 228, pp. 116481-116481
Open Access | Times Cited: 5
Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study
Shiau‐Shian Huang, Hsi-Han Chen, Jui Wang, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer’s Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors
Nguyen Minh Quang, Trần Thái Hòa, Hoa Le Thi, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11076-11099
Open Access | Times Cited: 5
Pharmaceutical management of sexual dysfunction in men on antidepressant therapy
Ahmed M. Bakr, Amro A. El‐Sakka, Ahmed I. El‐Sakka
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 9, pp. 1051-1063
Closed Access | Times Cited: 7
Terazosin produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress behavioral alteration
Nirav Bhatia, Gaurav Doshi
Neuroscience Letters (2024) Vol. 822, pp. 137653-137653
Closed Access | Times Cited: 1
Role of histone deacetylase inhibitors in non-neoplastic diseases
Chunxiao Zhou, Dengke Zhao, Chunyan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33997-e33997
Open Access | Times Cited: 1
The Flavonoid Fisetin Reduces Multiple Physiological Risk Factors for Dementia
Pamela Maher
Neurochemistry International (2024) Vol. 178, pp. 105805-105805
Closed Access | Times Cited: 1
Advances in Antidepressant Therapy: Comparing the Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and Novel Agents
Amber Nawaz, Beena Mamoon, Tashbiha E Batool, et al.
Cureus (2024)
Open Access | Times Cited: 1
Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder
Marco Paolini, L. Fortaner-Uyà, Cristina Lorenzi, et al.
Genes (2023) Vol. 14, Iss. 11, pp. 2037-2037
Open Access | Times Cited: 3
4-F-PCP, a Novel PCP Analog Ameliorates the Depressive-Like Behavior of Chronic Social Defeat Stress Mice via NMDA Receptor Antagonism
Darlene Mae Ortiz, Mikyung Kim, Hyun Jun Lee, et al.
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 2, pp. 227-239
Open Access | Times Cited: 1
Treatment-Resistant Depression and Medications
Syed Iqbal, Kirti Saxena, Amir Lateef, et al.
Psychiatric Annals (2024) Vol. 54, Iss. 6
Closed Access
Investigating the Antidepressant Impact of Ethanolic Extract of Melilotus officinalis Fruit in Mouse Models
Gustavo Roberto Villas Boas, Ana Paula Stefanello da Silveira, Brunna Charlla Feitosa Farinelli, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2024) Vol. 14, Iss. 6, pp. 21-27
Closed Access
Recent advances and challenges in major depressive disorder
Yong‐Ku Kim
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110403-110403
Closed Access | Times Cited: 2
EXPLANATION OF THE MOLECULAR MECHANISM OF ANTI-DEPRESSION THERAPY USING WEBINARS AS LEARNING COMMUNICATION MEDIA
Adhe Septa Ryant Agus, Junaidi Khotib
Jurnal Layanan Masyarakat (Journal of Public Services) (2023) Vol. 7, Iss. 3, pp. 316-325
Open Access
Psychotherapy, pharmacotherapy, and their combination in the treatment of major depressive disorder: How well are we making use of available therapies?
Ingrid Nădășan, Gabriel Hancu
Acta Marisiensis. Seria Medica (2023) Vol. 69, Iss. 4, pp. 244-251
Open Access
Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistance depression in a 13-year nationwide cohort study
Shiau‐Shian Huang, Hsi-Han Chen, Jui Wang, et al.
Research Square (Research Square) (2020)
Open Access
Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study 
Shiau‐Shian Huang, Hsi-Han Chen, Jui Wang, et al.
Research Square (Research Square) (2020)
Open Access
ADVANCES IN TREATMENT OF MOOD DISORDERS
Asim A. Shah
Journal of Pakistan Psychiatric Society (2022) Vol. 19, Iss. 04, pp. 4-5
Open Access

Inés Moragrega, José Luis Rı́os, Luis José
Planta Medica (2021) Vol. 87, Iss. 09
Open Access
Page 1

Scroll to top